Archive for December 4th, 2008

Business Wire - Andrx Announces ANDA Filing for Cardizem LA

Thursday, December 4th, 2008

FORT LAUDERDALE, Fla. — Andrx Corporation (Nasdaq:ADRX) (”Andrx” or “Company”) today announced that it has a pending abbreviated new drug application (”ANDA”) with the United States Food and Drug Administration (”FDA”) for generic versions of Cardizem(R) LA (diltiazem HCl extended-release tablets), 120mg, 180mg, 240mg, 300mg, 360mg and 420mg strengths. Andrx initially filed its ANDA for the 420mg s…